Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen M Zimmermann

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Chemmedchem|July 4, 2020
Phospholipid Cyclosporine Prodrugs Targeted at Inflammatory Bowel Disease (IBD) Treatment: Design, Synthesis, and in Vitro ValidationJagadeesh Nagendra Manda, Milica Markovic, Ellen M Zimmermann, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 5, 2011
Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cellsPatricia Garcia, Phyllissa Schmiedlin-Ren, Jason S Mathias, et al.
Pharmaceutics|April 19, 2019
Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico SimulationsMilica Markovic, Arik Dahan, Shahar Keinan, et al.
Current Topics in Medicinal Chemistry|April 19, 2016
Phospholipid-Based Prodrugs for Drug Targeting in Inflammatory Bowel Disease: Computational Optimization and In-Vitro CorrelationArik Dahan, Shimon Ben-Shabat, Noa Cohen, et al.
Journal of Computer-Aided Molecular Design|November 5, 2017
Computational modeling and in-vitro/in-silico correlation of phospholipid-based prodrugs for targeted drug delivery in inflammatory bowel diseaseArik Dahan, Milica Markovic, Shahar Keinan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 20, 2017
Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel diseaseArik Dahan, Milica Markovic, Svetlana Epstein, et al.
Journal of Healthcare Leadership|February 6, 2020
Characteristics of Faculty at Risk of Leaving Their Medical Schools: An Analysis of the StandPoint™ Faculty Engagement SurveyEllen M Zimmermann, Lazarus K Mramba, Hamleen Gregoire, et al.
Molecular Pharmaceutics|December 6, 2005
Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epitheliumFilippos Kesisoglou, Joel R Chamberlain, Phyllissa Schmiedlin-Ren, et al.
Gastroenterology Research and Practice|October 23, 2018
Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional SupportPatrick L Stoner, Amir Kamel, Fares Ayoub, et al.
Radiology|January 11, 2018
Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's DiseaseDavid H Bruining, Ellen M Zimmermann, Edward V Loftus, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Chemmedchem|July 4, 2020
Phospholipid Cyclosporine Prodrugs Targeted at Inflammatory Bowel Disease (IBD) Treatment: Design, Synthesis, and in Vitro ValidationJagadeesh Nagendra Manda, Milica Markovic, Ellen M Zimmermann, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 5, 2011
Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cellsPatricia Garcia, Phyllissa Schmiedlin-Ren, Jason S Mathias, et al.
Pharmaceutics|April 19, 2019
Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico SimulationsMilica Markovic, Arik Dahan, Shahar Keinan, et al.
Current Topics in Medicinal Chemistry|April 19, 2016
Phospholipid-Based Prodrugs for Drug Targeting in Inflammatory Bowel Disease: Computational Optimization and In-Vitro CorrelationArik Dahan, Shimon Ben-Shabat, Noa Cohen, et al.
Journal of Computer-Aided Molecular Design|November 5, 2017
Computational modeling and in-vitro/in-silico correlation of phospholipid-based prodrugs for targeted drug delivery in inflammatory bowel diseaseArik Dahan, Milica Markovic, Shahar Keinan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 20, 2017
Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel diseaseArik Dahan, Milica Markovic, Svetlana Epstein, et al.
Journal of Healthcare Leadership|February 6, 2020
Characteristics of Faculty at Risk of Leaving Their Medical Schools: An Analysis of the StandPoint™ Faculty Engagement SurveyEllen M Zimmermann, Lazarus K Mramba, Hamleen Gregoire, et al.
Molecular Pharmaceutics|December 6, 2005
Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epitheliumFilippos Kesisoglou, Joel R Chamberlain, Phyllissa Schmiedlin-Ren, et al.
Gastroenterology Research and Practice|October 23, 2018
Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional SupportPatrick L Stoner, Amir Kamel, Fares Ayoub, et al.
Radiology|January 11, 2018
Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's DiseaseDavid H Bruining, Ellen M Zimmermann, Edward V Loftus, et al.
Pageof 7